Free Trial
NASDAQ:AVR

Anteris Technologies Global (AVR) Stock Price, News & Analysis

Anteris Technologies Global logo
$6.86 +0.03 (+0.44%)
As of 04:00 PM Eastern

About Anteris Technologies Global Stock (NASDAQ:AVR)

Key Stats

Today's Range
$6.77
$6.97
50-Day Range
$5.59
$8.65
52-Week Range
$5.10
$8.79
Volume
197,123 shs
Average Volume
133,415 shs
Market Capitalization
$246.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.50
Consensus Rating
Buy

Company Overview

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Remove Ads
Receive AVR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Anteris Technologies Global and its competitors with MarketBeat's FREE daily newsletter.

AVR Stock News Headlines

Lake Street Remains a Buy on Anteris Technologies Global Corp. (AVR)
Crypto’s crashing…but we’re still profiting
Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess. The news is screaming fear. But while most traders watch their portfolios tank…
Anteris Technologies Global Corp. reports FY results
See More Headlines

AVR Stock Analysis - Frequently Asked Questions

Anteris Technologies Global's stock was trading at $5.58 at the beginning of 2025. Since then, AVR stock has increased by 22.9% and is now trading at $6.86.
View the best growth stocks for 2025 here
.

Anteris Technologies Global (AVR) raised $89 million in an IPO on Friday, December 13th 2024. The company issued 14,800,000 shares at a price of $6.00 per share.

Anteris Technologies Global's quiet period expired on Wednesday, January 22nd. Anteris Technologies Global had issued 14,800,000 shares in its initial public offering on December 13th. The total size of the offering was $88,800,000 based on an initial share price of $6.00. During Anteris Technologies Global's quiet period, insiders and underwriters involved in the IPO were prevented from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

Anteris Technologies Global's top institutional investors include Nantahala Capital Management LLC (4.64%), Regal Partners Ltd (3.60%), ADAR1 Capital Management LLC (2.93%) and Ensign Peak Advisors Inc (2.89%).

Shares of AVR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
3/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:AVR
Previous Symbol
NASDAQ:AVR
Web
N/A
Fax
N/A
Employees
138
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$16.50
High Stock Price Target
$22.00
Low Stock Price Target
$9.00
Potential Upside/Downside
+140.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.71 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$246.55 million
Optionable
N/A
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for March 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:AVR) was last updated on 3/14/2025 by MarketBeat.com Staff
From Our Partners